Raptiva Recall Lawsuit Trial Over Fatal Infection Delayed
The first trial over claims that the recalled psoriasis drug Raptiva caused a fatal brain infection has been pushed back to June.
The first trial over claims that the recalled psoriasis drug Raptiva caused a fatal brain infection has been pushed back to June.
Federal drug regulators are warning that the lymphoma drug Adcetris has been linked to potentially lethal brain infections and a risk of serious lung problems.
The label information on the multiple sclerosis drug Tysabri is being updated to reflect new data on the risk of a serious, and sometimes deadly, brain infection that has killed…
A Raptiva infection lawsuit has been filed by a Massachusetts man who claims that the recalled psoriasis drug caused him to develop meningitis and acute retinal necrosis, which left him…
A Texas man who was diagnosed with classic Hodgkin’s lymphoma has filed a Raptiva lawsuit, alleging that the recalled psoriasis drug caused him to develop the cancer.
Side effects of Raptiva may increase the risk of serious and potentially life-threatening injuries, such as infection, malignancy, lymphoma and death. The psoriasis drug was recalled in April 2009 because…
New cases of a rare brain infection, progressive multifocal leukoencephalopathy (PML), have been liked to the lymphoma and arthritis drug Rituxan and the multiple sclerosis (MS) drug Tysabri. The cases…
A new study indicates that side effects of Tysabri, a multiple sclerosis drug, reactivates and strengthens a virus that can cause a deadly brain infection, known as progressive multifocal leukoencephalopathy…
Biogen Idec Inc. is reporting that another brain infection from Tysabri has been discovered among users of their multiple sclerosis drug, which is at least the 10th case reported in…
A new case of a rare, often lethal, brain infection has been linked to the multiple sclerosis drug Tysabri, making it the ninth case of progressive multifocal leukoencephalopathy (PML) infection…